Results

Total Results: 1,932 records

Showing results for "question".

301. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_executive.pdf
     October 01, 2011 - Key Question 2. What are the harms of screening? … Key Question 3. … Key Question 4. … Key Question 3. … Key Question 4.

302. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
     February 01, 2008 - Key Question 2. How do patient characteristics affect outcomes? … Key Question 3. How do provider and hospital characteristics affect outcomes? … Key Question 4. How do tumor characteristics affect outcomes? … , conclusion, comments Key Question 1. … evidence Summary, conclusion, comments Key Question 4.

303. Colorectal-Cancer-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
     February 01, 2012 - Key Question 1. Clinical Utility. … of testing for Key Question 5. … Two studies for Key Question 2 also reported adherence to testing and are discussed with Key Question … Key Question 4. … Key Question 5.

304. Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review. Evidence Summary. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
     November 01, 2017 - Analytic framework Abbreviations: ACS=acute coronary syndrome; GI=gastrointestinal; KQ=Key Question; … Key Question 1 evidence summary Number of studies: 6 Study publication years: 2005-2013 Number of patients … Key Question 2 evidence summary Number of randomized clinical trials: 4 Number of patients: 3,119 Men … Strength of evidence for Key Question 2: CBT and second-generation antidepressant versus usual care … Strength of evidence for Key Question 2: Antidepressant medication versus usual care Outcome Number

305. Cancer-Anemia-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
     April 01, 2013 - This report addresses the following Key Questions: Key Question 1. … Key Question 2. … Key Question 3. … Conclusions Evidence from three groups of trials were summarized and analyzed for Key Question 1. … results from a meta-analysis of individual patient data.3 Additionally, three trials included in Key Question

306. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
     January 01, 2013 - Propose a definition of exposure that is consistent with the clinical/ conceptual basis for the research question … Exposure definition is dictated by the research question and is influenced by the physiological effects … The research question and the available data elements will usually define how the exposure is measured … Exposure definition is dictated by the research question and is influenced by the physiological effects … Exposure definition is dictated by the research question and is influenced by the physiological effects

307. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-6-protocol.pdf
     December 07, 2024 - Key Questions Key Question. … This review will update the literature for this Key Question from previous reviews.10,11,13-15 The PICOTS … 8. 2.4) (If Y, PY to previous question) were these deviations likely to have affected the outcome? … 16. 3.3) (If N/PN to previous question) Could missingness in the outcome depend on its true value? … 17. 3.4) (If Y, PY, NI to previous question) Is it likely that missingness in the outcome depended

308. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Key Question 2. 2a! … Key Question 4. … Key Question 3: Do these harms differ according to patient subgroup characteristics? … Severe rash (5% vs. 1%, RR 4.6, 95% CI 1.6 to 13) Key Question 3. … Key Question 4.

309. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Key Question 2. 2a! … Key Question 4. … Key Question 3: Do these harms differ according to patient subgroup characteristics? … Severe rash (5% vs. 1%, RR 4.6, 95% CI 1.6 to 13) Key Question 3. … Key Question 4.

310. Making Healthcare Safer IV Rapid Response_Active Surveillance Culturing of Clostridioides difficile and Multidrug-Resistant Organisms: Methicillin-Resistant Staphylococcus aureus, Carbapenem-Resistant Enterobacterales, and Candida auris (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
     May 01, 2024 - Our approach to Review Question 5 is described in detail below in Sections 2.1 through 2.4. … For Review Question 8, we sought to identify publicly available patient safety toolkits developed by … We also intended to include any toolkits mentioned in the studies found for Review Question 5. 2.1 … We found 6 studies that met the inclusion criteria for Review Question 5 (Figure 1). Figure 1. … Our searches did not identify any similar assessment of U.S. hospitals or labs. 3.2.7 Question 7.

311. Topic Brief: Antenatal Care (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
     April 01, 2021 - Two reviews were found which covered part of the question about the use of telehealth in antenatal care … Literature identified for each Question Question Systematic reviews (6/2017-6/2020) Primary studies … (6/2015-6/2020) Question 1: Antenatal care schedules Total: 0 • Cochrane: 0 • AHRQ: 0 • Other … : 0 Total: 0 • RCT: 0 • Controlled pre-post: 0 Clinicaltrials.gov • Recruiting: 0 Question … We classified identified studies by question and study design, to assess the size and scope of a potential

312. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
     December 11, 2012 - Peer Reviewer #5 Executive Summary Key Question 1a: utility of imaging 1. … Peer Reviewer #5 Executive Summary Key Question 5: Harm of work-up or treatment 1. … Peer Reviewer #5 Introduction Page 32, Line 24-5: Key Question 5: Harm of work-up or treatment 1. … We do not agree that asking the question encourages use. … Question #3 should also include an evaluation of the scrotal (Bianchi) orchiopexy.

313. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
     May 01, 2010 - Key Question 2. … Key Question 1. … Key Question 2. … Key Question 3a. … Key Question 3b.

314. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - Key Question 1b. … Key Question 2a. … Key Question 2b. … B-1 Key Question 1. … B-1 Key Question 2.

315. EBC-Challenge-Webinar-Transcript (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-webinar-transcript.pdf
     June 01, 2014 - Please  note  that you have the  option  to  send your question  to  us privately  by … And so actually our first question is a little bit on a related note. … So I think we’ve got a lot of great  feedback on that particular question. … Any thoughts on that question? Paul.   Yes, this  is Paul.   … That is a great question and of course that would be key.

316. Disposition of Comments Report for Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
     February 26, 2013 - We have provided explanations below the plots in question. Peer Reviewer 1 Results 5. … Jude Medical Key Question 1 In evaluating this question, it appears the draft report mixes intravascular … Jude Medical Key Question 2 For this question, we were somewhat confused regarding what is meant by … Jude Medical Key Question 4 As stated earlier in our comments, we believe a distinction should be … Jude Medical Key Question 5 In evaluating this question, we were confused in terms of what specifically

317. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
     April 01, 2013 - Key Question 1: 1a. … Key Question 2: 2a. … Key Question 4: 4. … Key Question 1. 1a. … Key Question 4. 4.

318. PowerPoint Presentation
     effectivehealthcare.ahrq.gov/sites/default/files/facilitation-webcast-slides.pptx
     June 13, 2013 - be sharing with you today. 4 Welcome What is a deliberative process and what is a deliberative question … We are saving about a half hour of time for question and answer after the presentation and hope to address … (next slide) 6 The overuse of antibiotics: focus group Question: How can doctors better communicate … (next slide) 7 The overuse of antibiotics: deliberative session Question: should there be more specific … What’s the question?

319. Association Between Outcomes and Dental Services in People at Risk of Post-Transplant Complications: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
     May 01, 2025 - Key Question 2: What are the clinical practice guidelines or standards for dental care for people at … Key Question 2: What are the clinical practice guidelines or standards for dental care for people at … PRISMA flow diagram 3.2 Key Question 1 Key Question 1: What is the effectiveness of dental services … Bold: statistically significant 3.3 Results, Key Question 2 10 3.3 Key Question 2 Key Question … 3.3 Key Question 2 3.3.1 Key Points 3.3.2 Included Guidelines 4.

320. Bladder-Cancer-Non-Muscle-Invasive Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
     July 21, 2014 - Based on additional input from a Technical Expert Panel (see section X below), the EPC removed a question … Key Question 4: For patients with high risk non-muscle-invasive bladder cancer treated with TURBT, what … Key Question 5: In surveillance of patients treated for non-muscle-invasive bladder cancer, what is … Key Question 8: What are the comparative adverse effects of various treatments for non- muscle-invasive … Systematic reviews will be used as primary sources of evidence if they address a key question and are